IOP-Lowering Efficacy of Brinzolamide 1.0% Added to Travoprost 0.004%/Timolol 0.5% Fixed Combination as Adjunctive Therapy
Status:
Completed
Trial end date:
2007-08-01
Target enrollment:
Participant gender:
Summary
Uncontrolled glaucoma patients being treated with a prostaglandin agent alone or in
combination with adjunctive drugs in fixed or unfixed combinations, will be switched from
their current therapy to travoprost/timolol fixed combination and either Azopt or placebo